Skip to main content
Premium Trial:

Request an Annual Quote

Intrinsic Bioprobes Gets $1.1M from NCI

NEW YORK (GenomeWeb News) – Intrinsic Bioprobes will measure cancer-related proteins and peptides that may improve diagnostic capabilities for disease, under a two-and-a-half year contract with the National Cancer Institute, the company said today.

Under the agreement, Intrinsic Bioprobes will receive $1.1 million from NCI, while the company will provide $146,000 toward the project.

The contract will support NCI's Clinical Proteomic Technologies for Cancer initiative, which focuses on assessing and using proteomics technologies and data resources to solve critical problems in cancer research.

Intrinsic Bioprobes focuses on mass spectrometry-based assays and platforms for rapid biomarker analysis, and its technologies include the Mass Spectrometric Immunoassay and the Bioreactive Mass Spectrometer Probes. These technologies are used in the firm's Massay System, which is a high-throughput mass spectrometry platform for rapid proteome analysis.

"The purpose of this contract is to stimulate the development of multiplex mass spectrometric immunoassay for the detection of low abundance cancer-related proteins/peptides from bodily fluids," Intrinsic Bioprobes Scientific Director Dobrin Nedelkov said in a statement.

The mass spectrometric immunoassays will bridge the gap between the clinical use of proteomics tools and their science and research applications, Nedelkov added, saying that they are highly specific and selective, have ultra-sensitive detection capabilities and broad dynamic range, and require limited sample preparation.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.